Onivyde
Irinotecan hydrochloride · Ipsen Biopharmaceuticals, Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Onivyde ingredients
| Active ingredient | Strength |
|---|---|
| Irinotecan Hydrochloride | 4.3 mg/mL |
What Onivyde is used for
Onivyde is a cancer medicine (topoisomerase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Onivyde
- Generic name
- Irinotecan hydrochloride
- Made by
- Ipsen Biopharmaceuticals, Inc.
- Forms
- Injection, Powder, For Solution
- Given
- Intravenous
- Drug class
- Topoisomerase Inhibitor
- FDA approval
- New drug application (NDA) NDA207793
- On the US market since
- 2015
Official information
- Onivyde prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Irinotecan hydrochloride)
In India
- Irinotecan hydrochloride: 34 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Onivyde?
Onivyde (Irinotecan hydrochloride) is a cancer medicine made by Ipsen Biopharmaceuticals, Inc., approved by the US FDA.
What are the ingredients of Onivyde?
Onivyde contains Irinotecan Hydrochloride (4.3 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA